Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
KeratoconusCorneal Ectasia
Interventions
DRUG

Riboflavin

Corneal epithelium removed followed by riboflavin drop administration every 2 minutes for 30 minutes followed by UV light exposure with additional riboflavin administration every 2 minutes for 30 minutes. Subjects will be randomized to receive Intacs placement either immediately before CXL or 3 months before CXL.

Trial Locations (1)

07666

Cornea and Laser Eye Institute, Teaneck

All Listed Sponsors
lead

Cornea and Laser Eye Institute

OTHER